~~<i id='9A25669291'><strike id='9A25669291'><tt id='9A25669291'><pre id='9A25669291'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

comprehensive

author：explore 2025-09-27 12:36:21 - browse：68

LONDON — AstraZeneca said Thursday it would purchase the French firm Amolyt Pharma in a deal worth up to $1 billion, picking up a rare disease drug in a pivotal trial.

The acquisition includes an upfront payment of $800 million in cash, plus another $250 million if regulatory milestones are met.

AstraZeneca framed the deal for Amolyt, which has focused on treatments for rare endocrine diseases, as a boost for its own rare disease pipeline.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： Illumina names Agilent executive as new CEO

focus

leisure time

knowledge

Wikipedia

focus

MollyFergusonforSTATWhatdoyousaytoapatientwhentheFDArejects“their”experimentaldrug—onethattheybeliev

WSS

New oral drug delivery patch is modeled after octopus tentacles

Stem cell treatment guidelines are released by FDA

Illumina names Agilent executive as new CEO

Experts study whether long Covid risk adds up with each reinfection

AstraZeneca chief proposes a novel edit to the drug pricing bill

New oral drug delivery patch is modeled after octopus tentacles

entertainment

comprehensive

focus

Medical records are filled with copy

Ethical issues complicate the benefits of medical crowdfunding

23andMe had bad news about my health. I wish a person had delivered it

Experts study whether long Covid risk adds up with each reinfection

23andMe had bad news about my health. I wish a person had delivered it

Why Novartis is changing the name of its research labs

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

With Roe v Wade overturned, abortion providers work to adapt

The high cost of giving birth even with insurance

The (many) problems with a new study criticizing cancer screening

leisure time

The United States is paying nearly triple for new Covid vaccines

Some top drug companies are starting to take action on climate

Advances in CAR

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

Congress extends some pandemic preparedness programs

Stem cell treatment guidelines are released by FDA

knowledge

Wikipedia

Wikipedia

focus